JPRN-UMIN000016446已完成未知
XELODA Special Drug Use Surveillance, XELOX as adjuvant chemotherapy for colon cancer - XELODA Special Drug Use Surveillance
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 65years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients <65 years old when starting XELOX therapy 2) Patients without serum creatinine data before XELOX therapy 3) Patients who did not start XELOX therapy at the specified initial dose 4) Patients with other cancers
研究者
相似试验
招募中
4 期
Post-marketing Surveillance Protocol Number; CABL001A1401Chronic myeloid leukemia resistant or intolerant to pretreatment drugsJPRN-jRCT2031220191Toshiya Sugimoto440
招募中
不适用
Special Drug Use Results Surveillance for the use of Odefsey in pregnant womeHIV/AIDSJPRN-UMIN000034028Janssen Pharmaceutical K.K.3
招募中
Unknown
Special drug use-results surveillance <Patients with cold agglutinin disease>Cold agglutinin diseaseJPRN-UMIN000049607sanofi K.K.100
招募中
4 期
Special Drug Use Surveillance of LIXIANA Tablet- Long-term use in patients with venous thromboembolismJPRN-UMIN000016387DAIICHI SANKYO COMPANY, LIMITED1,500
招募中
4 期
Special Drug Use Surveillance of LIXIANA Tablet- Long-term use in patients with non-valvular atrial fibrillationPrevention of ischemic stroke and systemic embolism in patients with non-valvular atrial fibrillation.JPRN-UMIN000017011DAIICHI SANKYO COMPANY, LIMITED10,000